Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

July 2, 2024

https://www.prnewswire.com/news-releases/lavie-bio-announces-commercial-expansion-of-yalos-to-winter-wheat-302187839.html

Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season

REHOVOT, Israel, July 2, 2024 /PRNewswire/ — Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), is pleased to announce the commercial expansion of its bio-inoculant product, Yalos™, to winter wheat, following successful trials. This expansion effectively doubles the potential market for Yalos™ compared to markets in which Lavie Bio already operates. Winter wheat growers across the US will have access to Yalos™ for the upcoming 2024-2025 season.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.